Related Experiment Video
Updated: Dec 3, 2025

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Serum Uric Acid may be Associated with Left Ventricular Diastolic Dysfunction in Military Individuals
Chung-Ming Tu1,2, Guo-Shiang Tseng3, Cheng-Wei Liu4,5
1Cardiology Division of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Insights
High serum uric acid (SUA) is linked to left ventricular diastolic dysfunction (LVDD) in military personnel. Keeping SUA levels normal may help prevent LVDD development.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Serum uric acid (SUA) is a metabolic byproduct.
- Left ventricular diastolic dysfunction (LVDD) is a common cardiac condition.
- The relationship between SUA and LVDD in military populations is not well-established.
Purpose of the Study:
- To investigate the correlation between serum uric acid levels and left ventricular diastolic dysfunction criteria.
- To determine the association between elevated SUA and LVDD in military individuals.
Main Methods:
- Prospective enrollment of 268 military individuals evaluated for electrocardiographic abnormalities.
- Definition of hyperuricemia as SUA ≥7 mg/dL (men) or ≥6 mg/dL (women).
- Assessment of LVDD criteria and left ventricular hypertrophy using echocardiographic guidelines.
Main Results:
- Serum uric acid showed weak correlations with left atrial diameter and left ventricular mass index (LVMI).
- The hyperuricemic group exhibited higher LVMI and increased prevalence of LVDD criteria (septal e' velocity <7 cm/s, lateral e' velocity <10 cm/s, average E/e' >14).
- Elevated SUA was significantly associated with septal e' velocity <7 cm/s in multivariate analysis (adjusted HR: 2.398).
Conclusions:
- Elevated serum uric acid is significantly associated with specific criteria for left ventricular diastolic dysfunction in military personnel.
- Maintaining normal SUA levels may be a strategy to prevent the development of LVDD.
Introduction:
We investigated the correlation and association between serum uric acid (SUA) and left ventricular diastolic dysfunction (LVDD) criteria in military individuals.
Material And Methods:
We prospectively enrolled military individuals who visited our hospital for evaluation of electrocardiographic abnormalities detected at an annual health exam between January 1, 2018 and December 31, 2019. Hyperuricemia was defined as an SUA level ≥7 mg/dL in men and ≥6 mg/dL in women. The definitions of LVDD criteria and LV hypertrophy were according to contemporary echocardiographic guidelines.
Results:
The study included 268 individuals (89% male), with a mean age of 32.9 ± 7.6 years and SUA of 6.1 ± 1.3 mg/dL. The hyperuricemic (n = 74) and normouricemic (n = 194) groups had no significant differences in lifestyle choices and baseline characteristics. Serum uric acid correlated weakly with heart size parameters (r = 0.354, P < .001 for left atrial diameter and r = 0.146, P = .017 for left ventricular mass index (LVMI) and average E/e' >14 (r = 0.204, P = .001). The hyperuricemic group had higher LVMI (87.6 g/m2 vs. 81.8 g/m2, P = .022), septal e' velocity <7 cm/s (14.9% vs. 5.2%, P = .019), lateral e' velocity <10 cm/s (27.0% vs. 11.3%, P = .003), and average E/e' >14 (4.1% vs. 0%, P = .020) values than the normouricemic group. In multivariate logistic regression analyses, SUA was significantly associated with septal e' velocity <7 cm/s (adjusted HR: 2.398; 95% CI, 1.427-4.030; P = .001).
Conclusion:
Elevated SUA was significantly associated with the presence of LVDD criteria, namely, septal e' velocity <7, in military individuals. Maintaining SUA levels within normal limits may prevent the development of LVDD.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy